Verfügbarkeit: Medizinische Chemie der neuen Arzneistoffe der Jahre 2011-2017

Medizinische Chemie der neuen Arzneistoffe der Jahre 2011-2017:

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	Asche, Christian (VerfasserIn)
Format:	Buch
Sprache:	German
Veröffentlicht:	Aachen Shaker Verlag 2018
Schlagworte:	Geschichte 2011-2017 Pharmakokinetik Arzneimittel Arzneimitteldosis Pharmazeutische Chemie Deutschland
Online-Zugang:	Inhaltsverzeichnis Inhaltsverzeichnis
Beschreibung:	XXI, 1376 Seiten Illustrationen 26 cm, 2600 g
ISBN:	9783844058963 3844058966

Internformat

MARC


LEADER	00000nam a2200000 c 4500
001	BV045244494
003	DE-604
005	20181031
007	t
008	181022s2018 a\|\|\| \|\|\|\| 00\|\|\| ger d
015			\|a 18,N18 \|2 dnb
015			\|a 18,A25 \|2 dnb
016	7		\|a 1156616859 \|2 DE-101
020			\|a 9783844058963 \|c Festeinband : EUR 169.00 (DE), EUR 169.00 (AT), CHF 211.30 (freier Preis) \|9 978-3-8440-5896-3
020			\|a 3844058966 \|9 3-8440-5896-6
024	3		\|a 9783844058963
035			\|a (OCoLC)1061549308
035			\|a (DE-599)DNB1156616859
040			\|a DE-604 \|b ger \|e rda
041	0		\|a ger
049			\|a DE-19
082	0		\|a 615.19 \|2 23/ger
082	0		\|a 615.58 \|2 23/ger
084			\|a VS 7000 \|0 (DE-625)147697:253 \|2 rvk
084			\|a 610 \|2 sdnb
084			\|a 540 \|2 sdnb
084			\|a 840 \|2 rpb
100	1		\|a Asche, Christian \|e Verfasser \|4 aut
245	1	0	\|a Medizinische Chemie der neuen Arzneistoffe der Jahre 2011-2017 \|c Christian Asche
264		1	\|a Aachen \|b Shaker Verlag \|c 2018
300			\|a XXI, 1376 Seiten \|b Illustrationen \|c 26 cm, 2600 g
336			\|b txt \|2 rdacontent
337			\|b n \|2 rdamedia
338			\|b nc \|2 rdacarrier
648		7	\|a Geschichte 2011-2017 \|2 gnd \|9 rswk-swf
650	0	7	\|a Pharmakokinetik \|0 (DE-588)4115557-9 \|2 gnd \|9 rswk-swf
650	0	7	\|a Arzneimittel \|0 (DE-588)4003115-9 \|2 gnd \|9 rswk-swf
650	0	7	\|a Arzneimitteldosis \|0 (DE-588)4214417-6 \|2 gnd \|9 rswk-swf
650	0	7	\|a Pharmazeutische Chemie \|0 (DE-588)4132158-3 \|2 gnd \|9 rswk-swf
651		7	\|a Deutschland \|0 (DE-588)4011882-4 \|2 gnd \|9 rswk-swf
689	0	0	\|a Deutschland \|0 (DE-588)4011882-4 \|D g
689	0	1	\|a Arzneimittel \|0 (DE-588)4003115-9 \|D s
689	0	2	\|a Pharmazeutische Chemie \|0 (DE-588)4132158-3 \|D s
689	0	3	\|a Pharmakokinetik \|0 (DE-588)4115557-9 \|D s
689	0	4	\|a Arzneimitteldosis \|0 (DE-588)4214417-6 \|D s
689	0	5	\|a Geschichte 2011-2017 \|A z
689	0		\|5 DE-604
710	2		\|a Shaker Verlag \|0 (DE-588)1064118135 \|4 pbl
776	0	8	\|i Erscheint auch als \|n Online-Ausgabe \|a Asche, Christian \|t Medizinische Chemie der neuen Arzneistoffe der Jahre 2011-2017 \|d Aachen : Shaker, 2018 \|h Online-Ressource, 1400 Seiten, 643 Illustrationen
856	4	2	\|m B:DE-101 \|q application/pdf \|u http://d-nb.info/1156616859/04 \|3 Inhaltsverzeichnis
856	4	2	\|m DNB Datenaustausch \|q application/pdf \|u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030632629&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA \|3 Inhaltsverzeichnis
999			\|a oai:aleph.bib-bvb.de:BVB01-030632629

Datensatz im Suchindex

_version_	1804178983233781760
adam_text	INHALTSVERZEICHNIS NEUE ARZNEISTOFFE 2011.......................................................................1 ABIRATERONACETAT (ZYTIGA) ........................................................................... 3 APIXABAN (ELIQUIS).....................................................................................13 BELATACEPT (NULOJIX)...................................................................................21 BELIMUMAB (BENLYSTA)...............................................................................25 BOCEPREVIR (VICTRELIS) UND TELAPREVIR (INCIVO).........................................28 BROMFENAC (YELLOX)...................................................................................39 CABAZITAXEL (JEVTANA) .............................................................................. 42 CANNABIDIOL/DELTA-9-TETRAHYDROCANNABINOL (SATIVEX)...............................50 DEXAMFETAMIN (ATTENTIN) .......................................................................... 55 DEXMEDETOMIDIN (DEXDOR) ....................................................................... 58 EPOPROSTENOL (EPOPROSTENOL-ROTEXMEDICA)...............................................63 ERIBULIN (HALAVEN).....................................................................................70 FAMPRIDIN (FAMPYRA) ............................................................................... 74 FINGOLIMOD (GILENYA) ................................................................................ 77 IPILIMUMAB (YERVOY)..................................................................................83 LINAGLIPTIN (TRAJENTA).................................................................................85 MIKROBIELLE KOLLAGENASE (XIAPEX)............................................................. 92 PIRFENIDON (ESBRIET)...................................................................................99 PITAVASTATIN (LIVAZO)...............................................................................102 REGADENOSON (RAPISCAN).......................................................................113 RETIGABIN (TROBALT)..................................................................................119 TAFAMIDIS (VYNDAQEL)..............................................................................123 TICAGRELOR (BRILIQUE)................................................................................129 NEUE ARZNEISTOFFE 2012...................................................................135 ACLIDINIUMBROMID (EKLIRA GENUAIR) ....................................................... 137 AFLIBERCEPT (EYLEA).................................................................................. 143 AXITINIB (INLYTA)........................................................................................ 147 AZILSARTAN (EDARBI)..................................................................................152 BRENTUXIMAB VEDOTIN (ADCETRIS)..............................................................163 CEFTAROLINFOSAMIL (ZINFORNO).....................................................................170 CRIZOTINIB (XALKORI).................................................................................. 177 DAPAGLIFLOZIN (FORXIGA)............................................................................182 DECITABIN (DACOGEN)...............................................................................190 IVACAFTOR (KALYDECO)................................................................................197 NOMEGESTROLACETAT (ZOELY) ..................................................................... 202 PASIREOTID (SIGNIFOR)................................................................................207 PERAMPANEL (FYCOMPA) ......................................................................... 214 PIXANTRON (PIXUVRI)..................................................................................220 RILPIVIRIN (EDURANT / EVIPLERA) ............................................................... 224 RUXOLITINIB (JAKAVI)..................................................................................233 TEGAFUR + GIMERACIL + OTERACIL (TEYSUNO).............................................. 238 TIANEPTIN (TIANEURAX)..............................................................................248 VANDETANIB (CAPRELSA)............................................................................251 VEMURAFENIB (ZELBORAF) .......................................................................... 260 NEUE ARZNEISTOFFE 2013 .................................................................. 269 AFATINIB (GIOTRIF).......................................................................................271 BOSUTINIB (BOSULIF)...................................................................................278 CLEVIDIPIN (CLEVIPREX)..............................................................................284 COBICISTAT + ELVITEGRAVIR (STRIBILD) ........................................................... 289 COLESTILAN (BINDREN)...............................................................................298 DABRAFENIB (TAFINLAR)...............................................................................302 ENZALUTAMID (XTANDI)..............................................................................306 FIDAXOMICIN (DIFICLIR)...............................................................................312 INGENOLMEBUTAT (PICATO)..........................................................................317 LINACLOTID (CONSTELLA)..............................................................................323 LI PEGFI LG RASTIM (LONQUEX)........................................................................327 LISDEXAMFETAMIN (ELVANSE) .................................................................... 332 LIXISENATID (LYXUMIA)..............................................................................334 LOMITAPID (LOJUXTA).................................................................................341 LOXAPIN (ADASUVE)..................................................................................350 NEPAFENAC (NEVANAC).............................................................................354 OCRIPLASMIN (JETREA)...............................................................................358 PERTUZUMAB (PERJETA)..............................................................................362 POMALIDOMID (IMNOVID) .......................................................................... 367 PONATINIB (ICLUSIG)...................................................................................371 REGORAFENIB (STIVARGA)............................................................................377 TERIFLUNOMID (AUBAGIO)............................................................................380 VISMODEGIB (ERIVEDGE)............................................................................386 NEUE ARZNEISTOFFE 2014...................................................................393 ALBIGLUTID (EPERZAN)................................................................................395 ALIPOGENTIPARVOVEC (GLYBERA) ................................................................. 399 ATALUREN (TRANSLARNA*)..............................................................................403 AVANAFIL (SPEDRA)....................................................................................410 BEDAQUILIN (SIRTURO).................................................................................416 CABOZANTINIB (COMETRIQ) ........................................................................ 420 CANAGLIFLOZIN (INVOKANA) ........................................................................ 425 CEFTOBIPROLMEDOCARIL (ZEVTERA) ............................................................... 430 CHLOROPROCAIN (AMPRES) ......................................................................... 434 CHOLSAEURE (ORPHACOL) ............................................................................ 437 DEFIBROTID (DEFITELIO)................................................................................439 DELAMANID (DELTYBA)...............................................................................441 DEXLANSOPRAZOL (DEXILANT) ...................................................................... 445 DIMETHYLFUMARAT (TECFIDERA) .................................................................. 450 DOLUTEGRAVIR (TIVICAY) ............................................................................. 453 ELOSULFASE ALFA (VIMIZIM).........................................................................460 EMPAGLIFLOZIN (JARDIANCE)........................................................................464 IBRUTINIB (IMBRUVICA) ........................................................................... 468 IDELALISIB (ZYDELIG)...................................................................................473 INSULIN DEGLUDEC (TRESIBA) ...................................................................... 476 LEDIPASVIR + SOFOSBUVIR (HARVONI).......................................................... 480 LEVOSIMENDAN (SIMDAX) ........................................................................ 484 LURASIDON (LATUDA)..................................................................................488 MACITENTAN (OPSUMIT) ............................................................................ 491 METYRAPON (METOPIRON) ........................................................................... 496 MIRABEGRON (BETMIGA).............................................................................499 NALMEFEN (SELINCRO)................................................................................503 OBINUTUZUMAB (GAZYVARO) ..................................................................... 507 OLODATEROL (STRIVERDI RESPIMAT) ........................................................... 512 PEGINTERFERON-SS-1 A (PLEGRIDY) ................................................................. 517 RADIUM-223-DICHLORID (XOFIGO) ............................................................... 520 RIOCIGUAT (ADEMPAS)..............................................................................522 SILTUXIMAB (SYLVANT)................................................................................527 SIMOCTOCOG ALFA (NUWIQ).........................................................................530 SOFOSBUVIR (SOVALDI)................................................................................531 SIMEPREVIR (OLYSIO).................................................................................531 DACLATASVIR (DAKLINZA).............................................................................531 SOFOSBUVIR............................................................................................. 534 SIMEPREVIR............................................................................................ 537 DACLATASVIR............................................................................................ 540 TEDUGLUTID (REVESTIVE)............................................................................543 TELAVANCIN (VIBATIV)................................................................................547 TRASTUZUMAB EMTANSIN (KADCYLA) .......................................................... 552 TUROCTOCOG ALFA (NOVOEIGHT) .................................................................. 558 UMECLIDINIUMBROMID (ANORO) ................................................................. 563 VEDOLIZUMAB (ENTYVIO) ........................................................................... 571 VILANTEROL (RELVAR ELLIPTA) ..................................................................... 574 NEUE ARZNEISTOFFE 2015...................................................................583 ALIROCUMAB (PRALUENT).............................................................................585 APREMILAST (OTEZLA).................................................................................587 ASFOTASE ALFA (STRENSIQ)...........................................................................593 BLINATUMOMAB (BLINCYTO).........................................................................596 CANGRELOR (KENGREXAL).............................................................................600 CARFILZOMIB (KYPROLIS)..............................................................................614 CERITINIB (ZYKADIA)...................................................................................620 COBIMETINIB (COTELLIC)..............................................................................625 DULAGLUTID (TRULICITY)................................................................................629 EDOXABAN (LIXIANA).................................................................................633 ELIGIUSTAT (CERDELGA)...............................................................................636 EVOLOCUMAB (REPATHA)...........................................................................644 IDEBENON (RAXONE).................................................................................647 ISAVUCONAZOL (CRESEMBA) ...................................................................... 650 IVERMECTIN (SOOLANTRA).............................................................................654 LENVATINIB (LENVIMA)..............................................................................658 LUMACAFTOR + IVACAFTOR (ORKAMBI) .......................................................... 661 NALOXEGOL (MOVENTIG)..............................................................................667 NETUPITANT + PALONOSETRON (AKYNZEO) .................................................... 669 NINTEDANIB (VARGATEF)..............................................................................674 NIVOLUMAB (OPVIDO)................................................................................680 NONACOG GAMMA (RIXUBIS) .................................................................... 683 OLAPARIB (LYNPARZA)................................................................................686 OMBITASVIR + PARITAPREVIR + RITONAVIR (VIEKIRAX)......................................691 DASABUVIR (EXVIERA)................................................................................691 PARITAPREVIR........................................................................................... 693 OMBITASVIR............................................................................................ 695 DASABUVIR............................................................................................. 697 PANOBINOSTAT (FARYDAK)...........................................................................700 PEMBROLIZUMAB (KEYTRUDA) .................................................................... 705 RAMUCIRUMAB (CYRAMZA)........................................................................709 SAFINAMID (XADAGO)................................................................................714 SEBELIPASE ALFA (KANUMA) ...................................................................... 717 SECUKINUMAB (COSENTYX) ....................................................................... 719 TEDIZOLID (SIVEXTRO).................................................................................722 TRAMETINIB (MEKINIST)..............................................................................728 VASOPRESSIN (EMPRESSIN) ....................................................................... 732 VORTIOXETIN (BRINTELLIX) ............................................................................. 734 NEUE ARZNEISTOFFE 2016...................................................................737 AFAMELANOTID (SCENESSE)........................................................................739 ALBUTREPENONACOG ALFA (IDELVION) ........................................................... 744 BRIVARACETAM (BRIVIACT)............................................................................749 DALBAVANCIN (XYDALBA)............................................................................754 DARATUMUMAB (DARZALEX)........................................................................765 DINUTUXIMAB (UNITUXIN)............................................................................770 EFMOROCTOCOG ALFA (ELOCTA)......................................................................779 EFTRENONACOG ALFA (ALPROLIX).....................................................................784 ELBASVIR + GRAZOPREVIR (ZEPATIER) ........................................................... 790 ELOTUZUMAB (EMPLICITI)............................................................................801 GUANFACIN (INTUNIV).................................................................................806 IDARUCIZUMAB (PRAXBIND).........................................................................812 MEPOLIZUMAB (NUCALA)............................................................................815 MIGALASTAT (GALAFOLD)...............................................................................817 MILNACIPRAN (MILNANEURAX) ...................................................................... 824 NECITUMUMAB (PORTRAZZA) ...................................................................... 831 OLARATUMAB (LARTRUVO).............................................................................636 OPICAPON (ONGENTYS)..............................................................................844 OSIMERTINIB (TAGRISSO).............................................................................857 OSPEMIFEN (SENSHIO)..............................................................................864 PALBOCICLIB (IBRANCE)...............................................................................870 PITOLISANT (WAKIX)....................................................................................879 PIVMECILLINAM (X-SYSTO)..........................................................................885 SACUBITRIL-VALSARTAN (LCZ696) (ENTRESTO)............................................... 886 SELEXIPAG (UPTRAVI).................................................................................895 SUSOCTOCOG ALFA (OBIZUR)........................................................................901 TALIMOGEN LAHERPAREPVEC (IMLYGIC) ........................................................ 904 TASIMELTEON (HETLIOZ)..............................................................................907 TRIFLURIDIN + TIPIRACIL (LONSURF) ................................................................ 912 MEDIZINISCHE CHEMIE DER NEUEN ARZNEISTOFFE VELPATASVIR + SOFOSBUVIR (EPCLUSA) ........................ INHALTSVERZEICHNIS .................. 920 NEUE ARZNEISTOFFE 2017...................................................................925 ALECTINIB (ALECENSA)................................................................................ 927 AVELUMAB (BAVENCIO) / ATEZOLIZUMAB (TECENTRIQ)................................936 AVELUMAB (BAVENCIO).........................................................................942 ATEZOLIZUMAB (TECENTRIQ)...................................................................949 AVIBACTAM + CEFTAZIDIM (ZAVICEFTA) ....................................................... 953 BARICITINIB (OLUMIANT)..............................................................................966 BRODALUMAB (KYNTHEUM).........................................................................974 CENEGERMIN (OXERVATE)..........................................................................979 CERLIPONASE ALFA (BRINEURA) .................................................................... 991 CHENODESOXYCHOLSAEURE (CHENODESOXYCHOLSAEURE LEADIANT) .................. 998 DUPILUMAB (DUPIXENT)........................................................................... 1003 ETELCALCETID (PARSABIV).......................................................................... 1016 FOLLITROPIN DELTA (REKOVELLE)..................................................................1028 GLECAPREVIR + PIBRENTASVIR (MAVIRET)......................................................1038 VOXILAPREVIR + VELPATASVIR + SOFOSBUVIR (VOSEVI) .................................. 1038 GLECAPREVIR UND VOXILAPREVIR (NS3/4A-LNHIBITOREN) ............................. 1041 PIBRENTASVIR (NS5A-LNHIBITOR)..............................................................1051 GUSELKUMAB (TREMFYA)......................................................................... 1062 INOTUZUMAB OZOGAMICIN (BESPONSA) ................................................... 1081 IXAZOMIBCITRAT (NINLARO)......................................................................... 1099 IXEKIZUMAB (TALTZ)................................................................................ 1106 LANDIOLOL (RAPIBLOC).............................................................................. 1111 LONOCTOCOG ALFA (AFSTYLA)...................................................................... 1120 MIDOSTAURIN (RYDAPT)............................................................................ 1125 NABILON (CANEMES)............................................................................... 1147 NIRAPARIP (ZEJULA).................................................................................. 1151 NONACOG BETA PEGOL (REFIXIA)................................................................1169 NUSINERSEN (SPINRAZA).......................................................................... 1194 OBETICHOLSAEURE (OCALIVA)......................................................................1224 REKOMBINANTES PARATHYROIDHORMON (NATPAR) ....................................... 1237 RESLIZUMAB (CINQAERO)......................................................................... 1256 RIBOCICLIB (KISQALI)................................................................................ 1265 ROLAPITANT (VARUBY)............................................................................... 1274 SARILUMAB (KEVZARA).............................................................................1291 TELOTRISTATETHYL (XERMELO)...................................................................... 1308 TIVOZANIB (FOTIVDA)............................................................................... 1328 TOFACITINIB (XELJANZ).............................................................................. 1336 VENETOCLAX (VENCLYXTO).........................................................................1344
any_adam_object	1
author	Asche, Christian
author_facet	Asche, Christian
author_role	aut
author_sort	Asche, Christian
author_variant	c a ca
building	Verbundindex
bvnumber	BV045244494
classification_rvk	VS 7000
ctrlnum	(OCoLC)1061549308 (DE-599)DNB1156616859
dewey-full	615.19 615.58
dewey-hundreds	600 - Technology (Applied sciences)
dewey-ones	615 - Pharmacology and therapeutics
dewey-raw	615.19 615.58
dewey-search	615.19 615.58
dewey-sort	3615.19
dewey-tens	610 - Medicine and health
discipline	Chemie / Pharmazie Medizin
era	Geschichte 2011-2017 gnd
era_facet	Geschichte 2011-2017
format	Book
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02504nam a2200589 c 4500</leader><controlfield tag="001">BV045244494</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20181031 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">181022s2018 a\|\|\| \|\|\|\| 00\|\|\| ger d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">18,N18</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">18,A25</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1156616859</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783844058963</subfield><subfield code="c">Festeinband : EUR 169.00 (DE), EUR 169.00 (AT), CHF 211.30 (freier Preis)</subfield><subfield code="9">978-3-8440-5896-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3844058966</subfield><subfield code="9">3-8440-5896-6</subfield></datafield><datafield tag="024" ind1="3" ind2=" "><subfield code="a">9783844058963</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1061549308</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1156616859</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.19</subfield><subfield code="2">23/ger</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.58</subfield><subfield code="2">23/ger</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 7000</subfield><subfield code="0">(DE-625)147697:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">540</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">840</subfield><subfield code="2">rpb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Asche, Christian</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Medizinische Chemie der neuen Arzneistoffe der Jahre 2011-2017</subfield><subfield code="c">Christian Asche</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Aachen</subfield><subfield code="b">Shaker Verlag</subfield><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXI, 1376 Seiten</subfield><subfield code="b">Illustrationen</subfield><subfield code="c">26 cm, 2600 g</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="648" ind1=" " ind2="7"><subfield code="a">Geschichte 2011-2017</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakokinetik</subfield><subfield code="0">(DE-588)4115557-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimitteldosis</subfield><subfield code="0">(DE-588)4214417-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Chemie</subfield><subfield code="0">(DE-588)4132158-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Deutschland</subfield><subfield code="0">(DE-588)4011882-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Deutschland</subfield><subfield code="0">(DE-588)4011882-4</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Pharmazeutische Chemie</subfield><subfield code="0">(DE-588)4132158-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Pharmakokinetik</subfield><subfield code="0">(DE-588)4115557-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="4"><subfield code="a">Arzneimitteldosis</subfield><subfield code="0">(DE-588)4214417-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="5"><subfield code="a">Geschichte 2011-2017</subfield><subfield code="A">z</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Shaker Verlag</subfield><subfield code="0">(DE-588)1064118135</subfield><subfield code="4">pbl</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="a">Asche, Christian</subfield><subfield code="t">Medizinische Chemie der neuen Arzneistoffe der Jahre 2011-2017</subfield><subfield code="d">Aachen : Shaker, 2018</subfield><subfield code="h">Online-Ressource, 1400 Seiten, 643 Illustrationen</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">B:DE-101</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://d-nb.info/1156616859/04</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030632629&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030632629</subfield></datafield></record></collection>
geographic	Deutschland (DE-588)4011882-4 gnd
geographic_facet	Deutschland
id	DE-604.BV045244494
illustrated	Illustrated
indexdate	2024-07-10T08:12:38Z
institution	BVB
institution_GND	(DE-588)1064118135
isbn	9783844058963 3844058966
language	German
oai_aleph_id	oai:aleph.bib-bvb.de:BVB01-030632629
oclc_num	1061549308
open_access_boolean
owner	DE-19 DE-BY-UBM
owner_facet	DE-19 DE-BY-UBM
physical	XXI, 1376 Seiten Illustrationen 26 cm, 2600 g
publishDate	2018
publishDateSearch	2018
publishDateSort	2018
publisher	Shaker Verlag
record_format	marc
spelling	Asche, Christian Verfasser aut Medizinische Chemie der neuen Arzneistoffe der Jahre 2011-2017 Christian Asche Aachen Shaker Verlag 2018 XXI, 1376 Seiten Illustrationen 26 cm, 2600 g txt rdacontent n rdamedia nc rdacarrier Geschichte 2011-2017 gnd rswk-swf Pharmakokinetik (DE-588)4115557-9 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf Arzneimitteldosis (DE-588)4214417-6 gnd rswk-swf Pharmazeutische Chemie (DE-588)4132158-3 gnd rswk-swf Deutschland (DE-588)4011882-4 gnd rswk-swf Deutschland (DE-588)4011882-4 g Arzneimittel (DE-588)4003115-9 s Pharmazeutische Chemie (DE-588)4132158-3 s Pharmakokinetik (DE-588)4115557-9 s Arzneimitteldosis (DE-588)4214417-6 s Geschichte 2011-2017 z DE-604 Shaker Verlag (DE-588)1064118135 pbl Erscheint auch als Online-Ausgabe Asche, Christian Medizinische Chemie der neuen Arzneistoffe der Jahre 2011-2017 Aachen : Shaker, 2018 Online-Ressource, 1400 Seiten, 643 Illustrationen B:DE-101 application/pdf http://d-nb.info/1156616859/04 Inhaltsverzeichnis DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030632629&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis
spellingShingle	Asche, Christian Medizinische Chemie der neuen Arzneistoffe der Jahre 2011-2017 Pharmakokinetik (DE-588)4115557-9 gnd Arzneimittel (DE-588)4003115-9 gnd Arzneimitteldosis (DE-588)4214417-6 gnd Pharmazeutische Chemie (DE-588)4132158-3 gnd
subject_GND	(DE-588)4115557-9 (DE-588)4003115-9 (DE-588)4214417-6 (DE-588)4132158-3 (DE-588)4011882-4
title	Medizinische Chemie der neuen Arzneistoffe der Jahre 2011-2017
title_auth	Medizinische Chemie der neuen Arzneistoffe der Jahre 2011-2017
title_exact_search	Medizinische Chemie der neuen Arzneistoffe der Jahre 2011-2017
title_full	Medizinische Chemie der neuen Arzneistoffe der Jahre 2011-2017 Christian Asche
title_fullStr	Medizinische Chemie der neuen Arzneistoffe der Jahre 2011-2017 Christian Asche
title_full_unstemmed	Medizinische Chemie der neuen Arzneistoffe der Jahre 2011-2017 Christian Asche
title_short	Medizinische Chemie der neuen Arzneistoffe der Jahre 2011-2017
title_sort	medizinische chemie der neuen arzneistoffe der jahre 2011 2017
topic	Pharmakokinetik (DE-588)4115557-9 gnd Arzneimittel (DE-588)4003115-9 gnd Arzneimitteldosis (DE-588)4214417-6 gnd Pharmazeutische Chemie (DE-588)4132158-3 gnd
topic_facet	Pharmakokinetik Arzneimittel Arzneimitteldosis Pharmazeutische Chemie Deutschland
url	http://d-nb.info/1156616859/04 http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030632629&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
work_keys_str_mv	AT aschechristian medizinischechemiederneuenarzneistoffederjahre20112017 AT shakerverlag medizinischechemiederneuenarzneistoffederjahre20112017

Verfügbarkeit

Es ist kein Print-Exemplar vorhanden.

Fernleihe Bestellen Achtung: Nicht im THWS-Bestand! Inhaltsverzeichnis
Inhaltsverzeichnis

MARC

Datensatz im Suchindex

Es ist kein Print-Exemplar vorhanden.

Ähnliche Einträge